Provided by Tiger Fintech (Singapore) Pte. Ltd.

Therapeutics

39.68
-0.3200-0.80%
Post-market: 39.28-0.4000-1.01%19:57 EDT
Volume:614.67K
Turnover:24.44M
Market Cap:1.13B
PE:-20.90
High:40.50
Open:40.00
Low:38.82
Close:40.00
52wk High:41.70
52wk Low:16.54
Shares:28.52M
Float Shares:13.13M
Volume Ratio:1.16
T/O Rate:4.68%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.8984
EPS(LYR):-2.3387
ROE:-26.25%
ROA:-18.44%
PB:5.48
PE(LYR):-16.97

Loading ...

Neurizon Therapeutics to Host Shareholder Webinar on ALS Treatment Developments

TIPRANKS
·
Aug 20

Cathie Wood ‘Buys the Dip’ in Robinhood, CRISPR, and Beam Therapeutics Stocks

TIPRANKS
·
Aug 20

Lava Therapeutics Reports Q2 2025 Financial Results

TIPRANKS
·
Aug 20

Neurizon Therapeutics Reports Positive Long-Term Results for ALS Treatment

TIPRANKS
·
Aug 20

Oral Weight Loss Drug "Crashes"! Viking Therapeutics Stock Plunges 42% as Short Sellers Reap $521 Million Overnight

Stock News
·
Aug 20

Vyome Holdings Completes Merger with Vyome Therapeutics

TIPRANKS
·
Aug 20

Versant Venture Capital VI, L.P. Reports Disposal of Common Shares of Lenz Therapeutics Inc

Reuters
·
Aug 20

Rein Therapeutics Shares Lower After Brookline Capital Downgrade

MT Newswires Live
·
Aug 20

Summit Therapeutics put volume heavy and directionally bearish

TIPRANKS
·
Aug 19

Edgewise Therapeutics Is Maintained at Overweight by JP Morgan

Dow Jones
·
Aug 19

Silexion Therapeutics Increases Authorized Share Capital

TIPRANKS
·
Aug 19

Viking Therapeutics Stock Plunges 40% as Obesity Drug Trial Data Falls Short of Expectations

Deep News
·
Aug 19

AbbVie Closes Acquisition of Capstan Therapeutics

MT Newswires Live
·
Aug 19

AbbVie completes acquisition of Capstan Therapeutics

TIPRANKS
·
Aug 19

Tango Therapeutics Initiated at Overweight by Piper Sandler

Dow Jones
·
Aug 19

Brookline Capital Downgrades Rein Therapeutics to Hold From Buy

MT Newswires Live
·
Aug 19

BioXcel Therapeutics Price Target Maintained With a $10.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 19

Piper Sandler Initiates Summit Therapeutics at Neutral With $21 Price Target

MT Newswires Live
·
Aug 19

Aligos Therapeutics: Promising Advancements in HBV Treatment and Strategic Pipeline Growth

TIPRANKS
·
Aug 19

Candel Therapeutics Advances with Promising Cancer Therapies

TIPRANKS
·
Aug 19